Education, EUGLOH, Research
SPOC MIRACIP: Management of immunorelated complication of cancer immunotherapy
… are the most promising drugs, they are associated with side effects in around 70% of treated patients, such called … those of traditional cancer therapies, and typically have delayed onset and prolonged duration. Some of them can be … Formation - training Formation - education EUGLOH Recherche - Research Réservé à certains publics Public …
Published on: